/Investor DB

LYZZ Capital — Full Portfolio

14 tracked investments · listed companies and verified rows first

Allotera Therapeuticsalloteratx.com

Allotera develops allogeneic (off-the-shelf) CAR-T cell therapies targeting T-cell cancers such as T-cell acute lymphoblastic leukemia, T-cell lymphoblastic lymphoma, and T-cell non-Hodgkin's lymphoma, as well as autoimmune indications.

BiotechHealthtechSt. Louis, US

Co-investorsAisling CapitalBioGenerator VenturesRiverVest Venture PartnersAbingworth

Alphabiopharmaalphabiopharma.com

A biopharmaceutical company developing oncology treatments including EGFR-targeting small molecule drugs for lung cancer with CNS penetration, and expanding into cell immunotherapy through licensed partnerships for NK cell and CAR-T therapies targeting solid tumors and hematologic malignancies.

BiotechDeep TechHealthtechMedical DevicesShanghai, CN

JUMPCODE Genomicsjumpcodegenomics.comin𝕏

Jumpcode Genomics develops CRISPRclean, a next-generation sequencing technology that removes abundant, uninformative sequences to improve sensitivity, lower costs, and simplify workflows for researchers.

AI & Machine LearningBiotechDeep TechHealthtechSan Diego, US

David Michael Salter(Executive Officer, Director)Mike Salter(CEO/President)inEugene Chen(Director)Keith Brown(Executive Officer, Director)Joel Rotroff(Director)

BoardCourt Turner(Director)

Co-investorsArboretum VenturesBaird CapitalGlobal Health Investment Corporation

Microtechmdmicrotechmd.comin𝕏

MicroTech Medical provides medical information services in China, with operational headquarters in Hangzhou and a principal place of business in Hong Kong.

Digital HealthHardwareMedical DevicesHangzhou, CN

Mark Dore(Founder)Pan Zheng(Founder)

Co-investorsLAVLilly Asia VenturesQiming Venture Partners

Mojiabiomojiabio.com

Mojiabio produces Aliphane, a bio-based chemical ingredient used in adhesives for applications including wood furniture, footwear, flexible packaging, automotive, and EV batteries.

AgTechBiotechCleantechNew Materials

Indra Jones Santanain

Co-investorsBits x Bites

Neurelisneurelis.comin𝕏

Neurelis is a neuroscience-based biopharmaceutical company that develops treatments for people living with neurological conditions such as epilepsy.

BiotechHealthtechMedical DevicesEncinitas, US

Craig Chambliss(Founder)in

BoardDavid F. Hale(Director)Cam Garner(Director)Yong Zhang(Director)Kevin Li(Director)in

Co-investorsHBM Healthcare InvestmentsHBM PartnersOrbiMed

Newmednewmed.cn

Shanghai NewMed Medical is a Chinese medical device company founded in 2015 that develops, manufactures, and sells transcatheter artificial heart valves and interventional ventricular assist systems.

BiotechHardwareHealthtechMedical DevicesShanghai, CN

Co-investorsOrbiMed

OncoMyx TherapeuticsinDec 2021

BiotechPhoenix, US

Douglas Grant McFadden, Ph.D.(Director)Steven J. Potts, Ph.D.(President and Chief Executive Officer)Ting Xiao(Director)Jason Rushton(Director)Kanad Das, Ph.D.(Director)Michael G. Wood(Executive Officer)

Co-investorsXeraya CapitalB Capital GroupBoehringer Ingelheim Venture FundCity Hill VenturesDelos CapitalKorea Investment Partners+1 more

Qpex Biopharmaqpexbio.comin𝕏

QpexBio develops anti-infective drugs designed to overcome multidrug resistance, improving existing drug classes and discovering new ones for use in combination with known anti-infectives against drug-resistant bacteria.

BiotechHealthtechSan Diego, US

Michael N. Dudley(Executive Officer, Director)inTerry Gould(Director)Daniel Burgess(Director)

BoardCarol Gallagher(Director)inDouglas Reed(Director)inKevin Li(Director)in

Co-investorsHatteras Venture PartnersNew Enterprise Associates (NEA)Adams Street Partners

Wugenwugen.comAug 2025 · $115M

Allotera (formerly Wugen) develops allogeneic T-cell therapies.

BiotechHealthtechMedical DevicesSt. Louis, US

Ayman Kabakibi(Executive Officer)inCherry Thomas(Executive Officer)inKumar Srinivasan(Executive Officer, Director)inKeith Vendola(Executive Officer)Daniel M Kemp(Executive Officer, Director)Matthew Cooper(Executive Officer)

Co-investorsAisling CapitalAlpha Wave GlobalBioGenerator VenturesRiverVest Venture PartnersAbingworthFidelity Investments

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

WxyuannuoYun300Zhiyunyilu

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.